GlassScriptPhysician profile
Michelle E Oglesby
NPI 1558522557
$3,555.16
in general payments reported to CMS, 2019-2025
19 companies · $656 in 2025
The $656 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $186 · 2021: $428 · 2022: $662 · 2023: $766 · 2024: $406 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,827.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $929.87 | 2019-2025 | Tryptyr, Clareon, Precision7 |
| Bausch & Lomb Americas INC. | $438.38 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $304.69 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $254.43 | 2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $244.80 | 2019-2022 | |
| Coopervision INC. | $218.71 | 2022-2024 | Misight Contact Lens, Myday Contact Lens |
| Oyster Point Pharma, INC. | $189.41 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $181.30 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $129.95 | 2024-2025 | Xdemvy |
| Rxsight INC | $129.50 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Glaukos Corporation | $123.04 | 2021 | |
| Biotissue Holdings INC. | $120.15 | 2021 | |
| Lkc Technologies, INC. | $117.33 | 2024 | |
| Derma Sciences, INC. | $66.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.52 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $18.44 | 2019 | |
| Aerie Pharmaceuticals, INC. | $17.27 | 2019 | |
| Allergan, INC. | $15.81 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $14.45 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Oglesby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.